Blank check company Bold Eagle Acquisition filed for a $250 million initial public offering on Friday with the Securities and Exchange Commission.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merit Medical Systems (MMSI – Research ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find ...

Brendan Smith, an analyst from TD Cowen, maintained the Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report). The associated ...

By providing a ready platform for cell engineering, Ginkgo is becoming a key service provider in the biotech industry, going beyond the pharmaceutical industry and into agriculture, biosecurity, and ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $6.81 which represents a slight increase of $0.58 or 9.31% from the prior close of $6.23. The stock opened at $6.37 and ...

The Functional Genomics product, the flagship offering under Ginkgo Datapoints, available now, delivers large-scale ...

Several labs will work with federal health authorities to develop a test for avian influenza, as the number of human cases ...

Bioengineering specialist Ginkgo Bioworks Holdings (NYSE: DNA) delivered some badly needed good news for investors on Tuesday ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein ...